Life Sciences Insights | McKinsey Company This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations
Transformations for life sciences companies | McKinsey Against this backdrop, we examined some 30 successful transformations undertaken by life sciences companies in the past five years, seeking to understand what has made them exceptions to the rule We found that all adhered to five transformation principles that we believe help explain their success
Transforming Healthcare and Life Sciences: Key Insights from McKinsey On May 31, 2025, a McKinsey survey revealed that 85% of leaders in healthcare—from payers to technology groups—are currently exploring or using generative AI technologies In the life sciences sector, generative AI could potentially unlock between $60 billion to $110 billion in value
R D skills for today: Rethinking the talent model | McKinsey Rapid advancements in science and technology are challenging pharma and biotech companies’ approaches to talent What R D skills do they need today, and how can they sustain this workforce?
Driving life sciences growth from productivity to performance . . . “ Clear, credible, compelling: Mastering investor engagement in life sciences ” explores how life sciences companies can strengthen investor relations by sharpening their equity stories, reinforcing credibility with proof points, and sustaining confidence through periods of volatility
Outlook on pharma operations - McKinsey Company A McKinsey study of over 30 global pharmacos shows average annual productivity increases of 7% over the past four years, which implies that productivity would double in a decade
Life Sciences consulting - McKinsey Company The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer